Job Creation through Capital Donation

SHINE Medical Technologies

SHINE (Janesville) is a next-generation nuclear technology company focused on deploying state-of-the-art fusion technology to help solve global problems as a scalable path to practical fusion energy. In 2021, SHINE merged with Phoenix, LLC and the combined company is working toward its long-term vision to advance fusion technology. Initially, the company’s fusion-based technology focuses on advanced industrial imaging and the production of diagnostic and therapeutic isotopes used in millions of heart and cancer patients each year. Longer term, SHINE is working to solve some of humanity’s biggest problems, including nuclear waste recycling and the production of clean fusion energy.

On March 17, 2022, the U.S. Department Energy and the Office of Science and Technology Policy hosted the “Vision for Commercial Fusion Energy” summit to address the future of this evolving technology. Shine founder Greg Piefer was one of the key leaders invited to participate in the discussion to help shape an updated fusion energy strategy.

For more information about SHINE Medical, see the news links below:

SHINE Building One Construction Complete

SHINE Medical Receives Regulatory Approval: Nuclear Regulatory Commission to Issue Construction Permit

Argonne Confirms New Commercial Method for Producing Medical Isotope

Argonne National Laboratory Demonstration of SHINE process Produces Commercial-Grade Medical Isotopes

National Science Foundation Award Helps SHINE Accelerate Efforts to Become a Major Domestic Producer of Iodine-131

Phoenix Nuclear and SHINE Complete Unprecedented Neutron Production Run

SHINE Announces Supply Agreement with Chinese Company


United States
Active Portfolio Item